Aubrey Reynolds | Senior Manager Investor Relations |
Doug Hirsch | Chief Mission Officer |
Trevor Bezdek | Chairman |
Karsten Voermann | Chief Financial Officer |
Scott Wagner | Interim Chief Executive Officer |
Stephanie Davis | SVB Leerink |
Sandy Draper | Guggenheim |
Charles Rhyee | Cowen |
Jian Li | Evercore ISI |
Michael Cherny | Bank of America |
Stan Berenshteyn | Wells Fargo |
Daniel Grosslight | Citigroup |
Jailendra Singh | Truist Securities |
Jonathan Yong | Credit Suisse |
Scott Schoenhaus | KeyBanc Capital Markets |
George Hill | Deutsche Bank |
Dylan Finley | UBS |
Steve Valiquette | Barclays |
Robert Simmons | D.A. Davidson |
Ladies and gentlemen, thank you for standing by. And welcome to the GoodRx First Quarter 2023 Earnings Call.
As a reminder, today's conference is being recorded.
I would now like to introduce your host for today's call, Aubrey Reynolds, Senior Manager of Investor Relations. Ms.